Treatment of human cytomegalovirus by modulating wnt
AssigneeThe Johns Hopkins University
InventorRavit Boger
Life of this patent
Estimating the term…
Abstract
The present invention relates to the field of virology. More specifically, the present invention provides methods and compositions useful for treating human cytomegalovirus using Wnt pathway modulators. In a specific embodiment, a method for treating human cytomegalovirus (HCMV) in a patient in need thereof comprises administering an effective amount of Wnt pathway modulator.
Claims16
A method for treating human cytomegalovirus (HCMV) in a patient in need thereof comprising administering an effective amount of Wnt pathway modulator.
A method for treating herpes simplex virus (HSV) in a patient in need thereof comprising administering an effective amount of Wnt pathway modulator.
A method for treating HCMV in a patient in need thereof comprising administering an effective amount of Wnt pathway modulator, wherein the modulator is monensin, nigericin, salinomycin or derivatives thereof.
A method for treating HSV in a patient in need thereof comprising administering an effective amount of Wnt pathway modulator, wherein the modulator is monensin, nigericin, salinomycin or derivatives thereof.
Dependencies are inferred from the claim text.